Similar articles for PMID: 22759213

Year	Number of Results
1979	1
1999	1
2000	1
2001	2
2003	3
2004	1
2005	2
2006	2
2007	2
2008	6
2009	11
2010	14
2011	10
2012	14
2013	22
2014	26
2015	20
2016	21
2017	15
2018	10
2019	8
2020	2
2021	5
2022	6
2024	0

1

The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms.

Kagan R. Kagan R. J Womens Health (Larchmt). 2012 Sep;21(9):975-81. doi: 10.1089/jwh.2011.3448. Epub 2012 Jul 3. J Womens Health (Larchmt). 2012. PMID: 22759213 Review.

2

Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.

Pickar JH, Mirkin S. Pickar JH, et al. Menopause Int. 2010 Sep;16(3):121-8. doi: 10.1258/mi.2010.010033. Menopause Int. 2010. PMID: 20956688 Review.

3

Tissue-selective estrogen complexes for postmenopausal women.

Mirkin S, Komm BS. Mirkin S, et al. Maturitas. 2013 Nov;76(3):213-20. doi: 10.1016/j.maturitas.2013.06.003. Epub 2013 Jul 11. Maturitas. 2013. PMID: 23849704 Review.

4

Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.

Komm BS, Mirkin S, Jenkins SN. Komm BS, et al. Steroids. 2014 Nov;90:71-81. doi: 10.1016/j.steroids.2014.06.004. Epub 2014 Jun 11. Steroids. 2014. PMID: 24929044 Review.

5

Treating menopausal symptoms with a tissue-selective estrogen complex.

Levine JP. Levine JP. Gend Med. 2011 Apr;8(2):57-68. doi: 10.1016/j.genm.2011.03.008. Gend Med. 2011. PMID: 21536225 Review.

6

Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.

Palacios S, Currie H, Mikkola TS, Dragon E. Palacios S, et al. Maturitas. 2015 Apr;80(4):435-40. doi: 10.1016/j.maturitas.2015.01.003. Epub 2015 Jan 24. Maturitas. 2015. PMID: 25684082 Review.

7

Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.

Pinkerton JV, Pickar JH, Racketa J, Mirkin S. Pinkerton JV, et al. Climacteric. 2012 Oct;15(5):411-8. doi: 10.3109/13697137.2012.696289. Epub 2012 Aug 1. Climacteric. 2012. PMID: 22853444 Review.

8

Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.

Pinkerton JV, Abraham L, Bushmakin AG, Cappelleri JC, Racketa J, Shi H, Chines AA, Mirkin S. Pinkerton JV, et al. J Womens Health (Larchmt). 2014 Jan;23(1):18-28. doi: 10.1089/jwh.2013.4392. Epub 2013 Nov 9. J Womens Health (Larchmt). 2014. PMID: 24206058 Clinical Trial.

9

Advances in menopausal therapy: the tissue-selective estrogen complex.

Moore A. Moore A. J Am Assoc Nurse Pract. 2013 Mar;25(3):126-33. doi: 10.1111/j.1745-7599.2012.00804.x. Epub 2012 Nov 26. J Am Assoc Nurse Pract. 2013. PMID: 24218199 Review.

10

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

Mirkin S, Komm BS, Pan K, Chines AA. Mirkin S, et al. Climacteric. 2013 Jun;16(3):338-46. doi: 10.3109/13697137.2012.717994. Epub 2012 Oct 5. Climacteric. 2013. PMID: 23038989 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

185 results

Results by year